Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 May 15;318(7194):1324-7.
doi: 10.1136/bmj.318.7194.1324.

Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation

A Howitt  1 , D Armstrong
Affiliations

Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation

A Howitt et al. BMJ. .

Abstract

Objective: To determine the extent to which implementation of an evidence based treatment, antithrombotic treatment in atrial fibrillation, is possible in general practice.

Design: Audit and qualitative study of patients with atrial fibrillation and an educational intervention for patients judged eligible for antithrombotic treatment.

Setting: South east England.

Subjects: 56 patients with a history of atrial fibrillation.

Interventions: Assessment and interview to ascertain patients' views on antithrombotic treatment.

Main outcome measures: Number of patients receiving antithrombotic treatment.

Results: Out of 13 239 patients, 132 had a history of atrial fibrillation of which 100 were at risk of thromboembolism. After the study, 52 patients were taking warfarin. Of the remaining 48 patients (of whom 41 were taking aspirin), eight were too ill to participate, 16 were unable to consent, four refused the interview, and 20 declined warfarin. Patients declining warfarin were inclined to seek a higher level of benefit than those taking it, as measured by the minimal clinically important difference. Qualitative data obtained during the interviews suggested that patients' health beliefs were important factors in determining their choice of treatment.

Conclusion: Patients' unwillingness to take warfarin seemed to be a major factor in limiting the number who would eventually take it.

PubMed Disclaimer

Figures

Figure
Figure
Pictorial representation of expected benefit of warfarin treatment shown to patients with predicted annual risk of stroke without any treatment of 12%
See this image and copyright information in PMC

Comment in

References

    1. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154:1449–1457. - PubMed
    1. Wheeldon NM, Tayler DI, Anagnostou E, Cook D, Wales C, Oakley GDG. Screening for atrial fibrillation in primary care. Heart. 1998;79:50–55. - PMC - PubMed
    1. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet. 1998;352:1167–1171. - PubMed
    1. Lip GYH, Golding DJ, Nazir M, Beevers DG, Child DL, Fletcher RI. A survey of atrial fibrillation in general practice: the West Birmingham atrial fibrillation project. Br J Gen Pract. 1997;47:285–289. - PMC - PubMed
    1. Taylor F, Ramsay M, Voke J, Cohen H. Anticoagulation in patients with atrial fibrillation. GPs not prepared for monitoring anticoagulation. BMJ. 1993;307:1493. - PMC - PubMed

Publication types

Substances